Cargando…
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias
BACKGROUND: The differential diagnosis of frontotemporal dementia (FTD) is still a challenging task due to its symptomatic overlap with other neurological diseases and the lack of biofluid-based biomarkers. OBJECTIVE: To investigate the diagnostic potential of a combination of novel biomarkers in ce...
Autores principales: | Bolsewig, Katharina, Hok-A-Hin, Yanaika S., Sepe, Federica N., Boonkamp, Lynn, Jacobs, Dirk, Bellomo, Giovanni, Paoletti, Federico Paolini, Vanmechelen, Eugeen, Teunissen, Charlotte E., Parnetti, Lucilla, Willemse, Eline A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661338/ https://www.ncbi.nlm.nih.gov/pubmed/36120776 http://dx.doi.org/10.3233/JAD-220318 |
Ejemplares similares
-
Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2021) -
Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023) -
Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases
por: van Engelen, Marie-Paule E, et al.
Publicado: (2023) -
Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2023) -
A Novel Neurofilament Light Chain ELISA Validated in Patients with Alzheimer’s Disease, Frontotemporal Dementia, and Subjective Cognitive Decline, and the Evaluation of Candidate Proteins for Immunoassay Calibration
por: Das, Shreyasee, et al.
Publicado: (2022)